310 related articles for article (PubMed ID: 33162992)
1. Clinical Significance of Serum Soluble TNF Receptor I/II Ratio for the Differential Diagnosis of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome From Other Autoinflammatory Diseases.
Yasumura J; Shimizu M; Toma T; Yashiro M; Yachie A; Okada S
Front Immunol; 2020; 11():576152. PubMed ID: 33162992
[No Abstract] [Full Text] [Related]
2. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum soluble TNF receptor II level and soluble TNF receptor II/I ratio as indicators of coronary artery lesion development in Kawasaki disease.
Shimizu M; Mizuta M; Usami M; Inoue N; Sakakibara Y; Yamada K; Konishi M; Ohta K; Yachie A
Cytokine; 2018 Aug; 108():168-172. PubMed ID: 29625336
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children.
Mizuta M; Shimizu M; Irabu H; Usami M; Inoue N; Nakagishi Y; Wada T; Yachie A
Rheumatology (Oxford); 2021 Jan; 60(1):231-238. PubMed ID: 32681176
[TBL] [Abstract][Full Text] [Related]
5. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
[TBL] [Abstract][Full Text] [Related]
6. [Periodic fever syndrome associated with mutations in the TNF type 1 receptor gene: A differential diagnosis of familial Mediterranean fever that should not be overlooked in patients of Mediterranean origin].
Bourguiba R; Savey L; Aouba A; Deshayes S; Fain O; Martin-Silva N; Hentgen V; Desdoits A; Grateau G; Giurgea I; Georgin-Lavialle S
Rev Med Interne; 2021 Jul; 42(7):459-464. PubMed ID: 33131906
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy.
Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Nakagishi Y; Yachie A
Pediatr Res; 2020 Dec; 88(6):934-939. PubMed ID: 32184444
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor receptor-associated periodic syndrome mimicking systemic juvenile idiopathic arthritis.
Manki A; Nishikomori R; Nakata-Hizume M; Kunitomi T; Takei S; Urakami T; Morishima T
Allergol Int; 2006 Sep; 55(3):337-41. PubMed ID: 17075277
[TBL] [Abstract][Full Text] [Related]
9. Overlap syndrome between Familial Mediterranean fever and tumor necrosis factor receptor-associated periodic syndrome in a lupus patient.
Nonaka F; Migita K; Iwasaki K; Shimizu T; Kawakami A; Yasunami M; Eguchi K
Tohoku J Exp Med; 2014 Jun; 233(2):73-7. PubMed ID: 24835548
[TBL] [Abstract][Full Text] [Related]
10. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin.
Wittkowski H; Frosch M; Wulffraat N; Goldbach-Mansky R; Kallinich T; Kuemmerle-Deschner J; Frühwald MC; Dassmann S; Pham TH; Roth J; Foell D
Arthritis Rheum; 2008 Dec; 58(12):3924-31. PubMed ID: 19035478
[TBL] [Abstract][Full Text] [Related]
11. S100A12 and vascular endothelial growth factor can differentiate Blau syndrome and familial Mediterranean fever from systemic juvenile idiopathic arthritis.
Yamasaki Y; Takei S; Imanaka H; Kubota T; Nonaka Y; Takezaki T; Kawano Y
Clin Rheumatol; 2019 Mar; 38(3):835-840. PubMed ID: 30406853
[TBL] [Abstract][Full Text] [Related]
12. Other autoinflammatory disease genes in an FMF-prevalent population: a homozygous MVK mutation and a novel heterozygous TNFRSF1A mutation in two different Turkish families with clinical FMF.
Karacan İ; Uğurlu S; Tolun A; Tahir Turanlı E; Ozdogan H
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):75-81. PubMed ID: 29148404
[TBL] [Abstract][Full Text] [Related]
13. Performance of recently proposed periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome criteria in a region endemic for familial Mediterranean fever.
Adrovic A; Yıldız M; Kanber M; Ulkersoy I; Gucuyener N; Koker O; Sahin S; Barut K; Kasapcopur O
Rheumatol Int; 2020 Jan; 40(1):91-96. PubMed ID: 31346686
[TBL] [Abstract][Full Text] [Related]
14. Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry.
Demirkaya E; Saglam C; Turker T; Koné-Paut I; Woo P; Doglio M; Amaryan G; Frenkel J; Uziel Y; Insalaco A; Cantarini L; Hofer M; Boiu S; Duzova A; Modesto C; Bryant A; Rigante D; Papadopoulou-Alataki E; Guillaume-Czitrom S; Kuemmerle-Deschner J; Neven B; Lachmann H; Martini A; Ruperto N; Gattorno M; Ozen S; ;
J Rheumatol; 2016 Jan; 43(1):154-60. PubMed ID: 26568587
[TBL] [Abstract][Full Text] [Related]
15. [A family of tumor necrosis factor receptor-associated periodic syndrome].
Li S; Ou RQ; Zhang BH; Zhang YN; Wang HY; Tan WP
Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):477-482. PubMed ID: 31216807
[No Abstract] [Full Text] [Related]
16. Cytokine profile of macrophage activation syndrome associated with Kawasaki disease.
Jinkawa A; Shimizu M; Nishida K; Kaneko S; Usami M; Sakumura N; Irabu H; Takakuwa M; Inoue N; Mizuta M; Ikawa Y; Fujita S; Yachie A
Cytokine; 2019 Jul; 119():52-56. PubMed ID: 30877950
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and genetic variants in patients with autoinflammatory diseases: results from the German GARROD registry.
Blank N; Kötter I; Schmalzing M; Rech J; Krause K; Köhler B; Kaudewitz D; Nitschke M; Haas CS; Lorenz HM; Krusche M
Rheumatol Int; 2024 Feb; 44(2):263-271. PubMed ID: 37747561
[TBL] [Abstract][Full Text] [Related]
18. Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor.
Magnotti F; Malsot T; Georgin-Lavialle S; Abbas F; Martin A; Belot A; Fauter M; Rabilloud M; Gerfaud-Valentin M; Sève P; Duquesne A; Hot A; Durupt S; Savey L; Giurgea I; Grateau G; Henry T; Jamilloux Y
Ann Rheum Dis; 2021 Jan; 80(1):128-132. PubMed ID: 33037005
[TBL] [Abstract][Full Text] [Related]
19. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
[TBL] [Abstract][Full Text] [Related]
20. Autoinflammatory Diseases with Periodic Fevers.
Sag E; Bilginer Y; Ozen S
Curr Rheumatol Rep; 2017 Jul; 19(7):41. PubMed ID: 28631068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
